AMPEL BioSolutions logo

AMPEL BioSolutions

Harnessing Data to Improve Lives through Genomics

28 employees · est. 2013 · Charlottesville, United Stat...

VS
Asterand logo

Asterand

Elevating drug discovery with unparalleled human tissue-based research tools and solutions, accelerating the path to clinical success.

51-200 employees · est. 2000

Asterand is the older company (2013 vs 2000); Asterand is the larger of the two.

Side-by-Side Comparison

AMPEL BioSolutions Asterand
Founded
2013 2000 older
Headquarters
Charlottesville, United States Not tracked yet
Employees
28 51-200 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Debt Financing Series C
Total Funding
$14.31M $3.00M
Funding Rounds
7 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Genomics Solutions, Biomedical Company, Drug Target Identification, Clinical Trials, Bioinformatics, Autoimmunity, Inflammation, Immunology, Systemic Lupus Erythematosus (SLE), Autoimmune And Inflammatory Diseases, Disease Biomarker Identification, Clinical Trial Management, Target Identification And Validation, Rheumatology Drug Discovery, Human Tissue Research, Biorepository, Bioscience, Pharmaceutical Research, Clinical Success, Target Identification, Drug Candidate Selection, Research Tools, Tissue Procurement, Compound Evaluation, Drug Safety, Bioinformatics, Life Sciences
Website
ampelbiosolutions.com asterand.com
AMPEL BioSolutions logo

About AMPEL BioSolutions

AMPEL BioSolutions is a biomedical company founded in 2013, with headquarters in the United States. The company's slogan, "Harnessing Data to Improve Lives through Genomics", encapsulates its dedication to leveraging data and clinical science to drive advancements in personalized medicine. AMPEL's f...

Asterand logo

About Asterand

Asterand Bioscience, a global leader in human tissue-based research tools and solutions for drug discovery, was formed in 2006 through the merger of Asterand and Pharmagene. It offers top-quality, well-characterized human tissue and research solutions to accelerate drug target identification and val...

We will tell you when either one moves

BounceWatch watches AMPEL BioSolutions and Asterand for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AMPEL BioSolutions and Asterand — by email.

Frequently Asked Questions

AMPEL BioSolutions — Harnessing Data to Improve Lives through Genomics. Asterand — Elevating drug discovery with unparalleled human tissue-based research tools and solutions, accelerating the path to clinical success.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AMPEL BioSolutions has raised $14.31M while Asterand has raised $3.00M.
AMPEL BioSolutions and Asterand operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AMPEL BioSolutions with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at AMPEL BioSolutions on 26 Jul 2024, and Asterand on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy